Trial Profile
The Efficacy of Diclofenac Gel for Breakthrough Pain and the Neuropathic Components of Pain in Knee Osteoarthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jul 2017
Price :
$35
*
At a glance
- Drugs Diclofenac (Primary)
- Indications Osteoarthritis; Pain
- Focus Therapeutic Use
- 23 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 May 2012 Planned End Date changed from 1 Aug 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 30 Jun 2011 New trial record